FDA Bans CFC Inhalers, Walmart Offers Low-Cost Alternative
An FDA mandate that came into effect on Dec. 31 dictates that all albuterol metered-dose asthma inhalers marketed in the U.S. must use hydrofluroalkane (HFA) propellants, as opposed to chlorofluorocarbon (CFC) propellants.
Most manufacturers, like GlaxoSmithKline (GSK) and Schering-Plough, hurried to make the transition and have increased production to ensure an adequate supply of HFA inhalers. Armstrong Pharmaceuticals has not yet done so, the FDA said.
Rescue inhalers can be costly: some HFA inhalers may sell for as much as $60 for certain brands. To make the life-saving medication affordable, Walmart is going to sell the ReliOn Ventolin HFA inhaler for $9.
Energy Manager News
- Mohegan Sun Pocono Casino Doesn’t Consider Cogeneration a Gamble
- Clean Power Plan: Obama’s Team Confident About Pitch to Supreme Court
- BuildingIQ Introduces Managed Services
- Solar Power Breakthrough Near?
- Battery Storage Giving Businesses a Break
- Could Ratepayers Foot the Bill for New Hampshire’s Pipelines?
- CenterPoint to Acquire Continuum’s Retail Energy Services Division
- LED Projects Must Be Carefully Planned